BioSpace News Archive

Business

TP Therapeutics Appoints Lewis Shuster to Board of Directors

TP Therapeutics, Inc., a privately held, clinical-stage biopharmaceutical company focusing on addressing oncology drug resistance, announced the appointment of Lewis “Lew” Shuster to the Company’s Board of Directors.

February 27, 2018
·
3 min read
Biotech Bay

AIVITA Biomedical to Participate at Upcoming February and March Aesthetic & Dermatology Conferences

AIVITA Biomedical, a global bio-tech wellness company specializing in novel stem cell applications, announced today its participation in three upcoming aesthetic and dermatology conferences in support of its recently launched ROOT OF SKIN™ and soon-to-launch ROOT OF SKIN™ MD skincare lines.

February 27, 2018
·
2 min read
Business

Xencor Reports Fourth Quarter and Full Year 2017 Financial Results

Xencor, Inc. reported financial results for the fourth quarter and full year ended December 31, 2017 and provided a review of 2017 and recent business and clinical highlights.

February 27, 2018
·
10 min read
Business

Intersect ENT Reports Fourth Quarter and Full Year 2017 Results

Intersect ENT, Inc. reported financial results for the fourth quarter and year ended December 31, 2017.

February 27, 2018
·
4 min read
Pharm Country

Celgene Provides Regulatory Update on Ozanimod for the Treatment of Relapsing Multiple Sclerosis

Celgene Corporation has received a Refusal to File letter from the United States Food and Drug Administration regarding its New Drug Application for ozanimod in development for the treatment of patients with relapsing forms of multiple sclerosis.

February 27, 2018
·
3 min read
Business

Five Prime Announces Fourth Quarter and Full Year 2017 Financial Results

Five Prime Therapeutics, Inc. provided a corporate update and reported financial results for the fourth quarter and full year ending December 31, 2017.

February 27, 2018
·
11 min read